I
Inhibrx
0 followers
Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.
Org chart
Mark P. Lappe
Founder & CEO
Mark P. Lappe
Collapse
Brendan P. Eckelman
Chief Scientific Officer & EVP Corporate Strategy
Kelly Deck
EVP & CFO
Ashraf Amanullah
EVP & Chief Technical Operations Officer
David Matly
Evp, Chief Commercial And Business Development Officer
Leah Pollema
General Counsel
David Kao
VP, Regulatory Affairs
Vasily Andrianov
VP, Clinical Development & Medical Affairs
Dana Ebbets-Reed
VP, Quality Assurance
Darren Brown
VP, Analytical Development & Quality Control
Robert Boothroyd
VP, Medical Affairs & Business Development
Brian Lobo
VP, Formulation Development & Drug Product Manufacturing
Melissa Masterson
VP, Value, Access & Distribution
Board & advisors
Douglas G. Forsyth
Director
Jon Faiz Kayyem
Director
Kimberly Manhard
Director
Kristiina Vuori
Director
Mark Brantly
Scientific Advisor
Robert A. Sandhaus
Scientific Advisor
Kenneth R. Chapman
Scientific Advisor
James Stoller
Scientific Advisor
Noel Gerry McElvaney
Scientific Advisor
Igor Barjaktarevic
Scientific Advisor
Teams
Offices
Similar companies
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
1 follower
Gilead Sciences
140 followers
Regeneron
107 followers
Illumina
74 followers
Agilent Technologies
76 followers
Verily Life Sciences
39 followers
Alexion Pharmaceuticals
36 followers
Explore companies